Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes

Abstract

Peptides that are antigenic for T lymphocytes are ligands for two receptors, the class I or II glycoproteins that are encoded by genes in the major histocompatibility complex, and the idiotypic α/β chain T-cell antigen receptor1-9. That a peptide must bind to an MHC molecule to interact with a T-cell antigen receptor is the molecular basis of the MHC restriction of antigen-recognition by T lymphocytes10,11. In such a trimolecular interaction the amino-acid sequence of the peptide must specify the contact with both receptors: agretope residues bind to the MHC receptor and epitope residues bind to the T-cell antigen receptor12,13. From a compilation of known antigenic peptides, two algorithms have been proposed to predict antigenic sites in proteins. One algorithm uses linear motifs in the sequence14, whereas the other considers peptide conformation and predicts antigenicity for amphipathic α-helices15,16. We report here that a systematic delimitation of an antigenic site precisely identifies a predicted pentapeptide motif as the minimal antigenic determinant presented by a class I MHC molecule and recognized by a cytolytic T lymphocyte clone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Thomas, D. W., Hsieh, K.-H., Schauster, J. L. & Wilner, G. D. J. exp. Med. 153, 583–594 (1981).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Shimonkevitz, R., Kappler, J., Marrack, P. & Grey, H. J. exp. Med. 158, 303–316 (1983).

    Article  CAS  PubMed  Google Scholar 

  3. Babbitt, B., Allen, P., Matsueda, G., Haber, E. & Unanue, E. Nature 317, 359–361 (1985).

    Article  ADS  CAS  PubMed  Google Scholar 

  4. Shastri, N., Oki, A., Miller, A. & Sercarz, E. E. J. exp. Med. 162, 332–345 (1985).

    Article  CAS  PubMed  Google Scholar 

  5. Townsend, A. et al. Cell 44, 959–968 (1986).

    Article  CAS  PubMed  Google Scholar 

  6. Bjorkman, P. J. et al. Nature 329, 506–518 (1987).

    Article  ADS  CAS  PubMed  Google Scholar 

  7. Buus, S., Sette, A., Colon, S., Miles, C. & Grey, H. Science 235, 1353–1358 (1987).

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Marrack, P. & Kappler, J. Science 238, 1073–1079 (1987).

    Article  ADS  CAS  PubMed  Google Scholar 

  9. Davis, M. M. & Bjorkman, P. J. Nature 334, 395–402 (1988).

    Article  ADS  CAS  PubMed  Google Scholar 

  10. Zinkernagel, R. M. & Doherty, P. C. Adv. Immun. 27, 51–177 (1979).

    Article  CAS  PubMed  Google Scholar 

  11. Schwartz, R. H. A. Rev. Immun. 3, 237–262 (1985).

    Article  CAS  Google Scholar 

  12. Allen, P. M. et al. Nature 327, 713–715 (1987).

    Article  ADS  CAS  PubMed  Google Scholar 

  13. Rothbard, J. B. et al. Cell 52, 515–523 (1988).

    Article  CAS  PubMed  Google Scholar 

  14. Rothbard, J. B. & Taylor, W. R. EMBO J. 7, 93–100 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. DeLisi, C. & Berzofsky, J. Proc. natn. Acad. Sci. U.S.A. 82, 7048–7052 (1985).

    Article  ADS  CAS  Google Scholar 

  16. Margalit, H. et al. J. Immun. 138, 2213–2229 (1987).

    CAS  PubMed  Google Scholar 

  17. Reddehase, M. J. & Koszinowski, U. H. Nature 312, 369–371 (1984).

    Article  ADS  CAS  PubMed  Google Scholar 

  18. Keil, G. M., Ebeling-Keil, A. & Koszinowski, U. H. J. Virol. 61, 1901–1908 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Koszinowski, U. H., Keil, G. M., Schwarz, H., Schickedanz, J. & Reddehase, M. J. J. exp. Med. 166, 289–294 (1987).

    Article  CAS  PubMed  Google Scholar 

  20. Volkmer, H., Bertholet, C., Jonjic, S., Wittek, R. & Koszinowski, U. H. J. exp. Med. 166, 668–677 (1987).

    Article  CAS  PubMed  Google Scholar 

  21. Del Val, M. et al. J. Virol. 62, 3965–3972 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Reddehase, M. J., Bühring, H.-J. & Koszinowski, U. H. J. Virol. 57, 408–412 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Reddehase, M. J. et al. Immunobiology 174, 420–431 (1987).

    Article  CAS  PubMed  Google Scholar 

  24. Bodmer, H. C., Pemberton, R. M., Rothbard, J. B. & Askonas, B. A. Cell 52, 253–258 (1988).

    Article  CAS  PubMed  Google Scholar 

  25. Schwartz, R. H., Fox, B. S., Fraga, E., Chen, C. & Singh, B. J. Immun. 135, 2598–2608 (1985).

    CAS  PubMed  Google Scholar 

  26. Good, M. F. et al. J. Immun. 140, 1645–1650 (1988).

    CAS  PubMed  Google Scholar 

  27. Oldstone, M. B. A., Whitton, J. L., Lewicki, H. & Tishon, A. J. exp. Med. 168, 559–570 (1988).

    Article  CAS  PubMed  Google Scholar 

  28. Sette, A. et al. Nature 328, 395–399 (1987).

    Article  ADS  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddehase, M., Rothbard, J. & Koszinowski, U. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337, 651–653 (1989). https://doi.org/10.1038/337651a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/337651a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing